The Board of Directors of HFCL Limited approved a plan to raise up to ₹555 crore by issuing up to 7,50,00,000 warrants convertible into equity shares to the Promoter/Promoter Group. The issue price is fixed at ₹74 per share. This strategic fund mobilization aims to strengthen the balance sheet, enhance financial flexibility, and support accelerated growth initiatives, including backward integration and scaling up the defence business.
Approval for Strategic Capital Raise
HFCL Limited announced the outcome of its Board Meeting held on March 25, 2026, where the proposal for raising capital through the preferential issue of warrants was approved. The company plans to issue up to 7,50,00,000 warrants, each convertible into one equity share.
The issue price has been set at ₹74/- per equity share, which aggregates to an approximate total of ₹555 crore. This issuance is exclusively targeted at the Promoters/Promoter Group category, signaling their continued commitment to the company’s long-term vision.
Key Objectives of the Fund Raise
The primary aim of this capital infusion is to fortify the Company’s balance sheet and increase financial flexibility as HFCL embarks on an accelerated phase of growth and strategic investments. Medium-term capital-intensive initiatives identified include:
- Backward integration into preform manufacturing to enhance margins and supply chain stability.
- Scaling up the defence business, identified as a high-growth segment.
- Augmenting long-term working capital to align with ongoing expansion programmes and anticipated incremental revenue generation.
Shareholding Impact and Terms
The proposed allotment will result in a significant increase in the Promoter/Promoter Group’s stake, moving their holding from 12.79% pre-allotment to 16.87% post-assuming full conversion of warrants. The two allottees are NextWave Communications Private Limited and Satellite Finance Private Limited.
Each warrant holder must pay 25% of the issue price upon subscription and allotment. The remaining 75% is payable upon the exercise of the warrant into equity shares. Warrants carry an exercise tenure of 18 months from the allotment date; failure to exercise within this period will result in the forfeiture of the initial 25% payment.
Next Steps and Governance
To proceed with this preferential issue, the approval of the shareholders is required at an ensuing Extra-Ordinary General Meeting (EGM), which the Board has approved convening on Friday, April 24, 2026. Furthermore, Mr. Baldev Singh Kashtwal has been appointed as the scrutinizer for the e-Voting process, and CARE Ratings Limited will serve as the monitoring agency for the utilization of the proceeds.
Source: BSE
